vTv Therapeutics Inc. - Class A Common Stock (VTVT): New Bullish Coverage

VTVT – Roth Capital initiates as a buy, $17PT. This price target represents a 170.70% upside over the stock’s previous closing price of $6.28.


Update: As of Dec. 7, 2018, this bullish analyst call has returned -69.27%.


Key Facts Surrounding This News Item


  • VTVT had a POWR Rating of C (Neutral) coming into today.
  • VTVT was 3.51% above its 10-Day Moving Average coming into today.
  • VTVT was -0.48% below its 20-Day Moving Average coming into today.
  • VTVT was 0.12% above its 50-Day Moving Average coming into today.
  • VTVT was 6.08% above its 100-Day Moving Average coming into today.
  • VTVT was 14.40% above its 200-Day Moving Average coming into today.
  • VTVT had returned +4.49% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About vTv Therapeutics Inc. – Class A Common Stock (VTVT)


vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina. View our full VTVT ticker page with ratings, news, and more.

VTVT at a Glance

VTVT Current POWR Rating™
Overall POWR Rating™
VTVT Current Price $1.93 6.31%
More VTVT Ratings, Data, and News

VTVT Price Reaction

The day of this event (Mar. 8, 2018)
VTVT Closing Price$6.46 2.87%
VTVT Volume207,200
116.72% from avg
Leading up to this event
VTVT 1-mo return7.92%
After this event
VTVT 1-day return2.18%
VTVT 3-day return2.94%
VTVT 5-day return10.76%

VTVT Price Chart


The Top Stocks For 2019

More vTv Therapeutics Inc. - Class A Common Stock (VTVT) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VTVT News
Page generated in 0.9108 seconds.